Medicare to get new advisory committee to assess technology coverage
This article was originally published in Clinica
The Health Care Financing Administration (HCFA) is to set up a new committee to help it decide whether certain medical technology in the US should be covered by Medicare reimbursement. In a Federal Register notice published on December 14, the agency announced it will establish a 120-member Medicare Coverage Advisory Committee (MCAC) to advise it on "whether medical items and services are reasonable and necessary".
You may also be interested in...
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.